Pizzolo F, Friso S, Olivieri O, Martinelli N, Bozzini C, Guarini P, Trabetti E, Faccini G, Corrocher R, Girelli D
Department of Clinical and Experimental Medicine, University of Verona School of Medicine, Verona, Italy.
Eur J Clin Invest. 2006 Oct;36(10):698-704. doi: 10.1111/j.1365-2362.2006.01714.x.
To establish whether the frequent finding of a moderate-intermediate increase in plasma total homocysteine (tHcy) causes coronary artery disease (CAD), the authors evaluated the number of coexisting major traditional risk factors, as well as the major tHcy determinants, in patients with the same degree of CAD but different tHcy levels.
The authors studied 180 patients with CAD, who were divided into three groups according to tHcy levels: 60 patients with normal tHcy, 60 patients with moderate (15-30 micromol L(-1)) and 60 patients with intermediate hyperhomocysteinaemia (30-100 micromol L(-1)). The patient groups were matched for gender, age and number of affected coronary vessels. All patients were checked for the presence of traditional risk factors for CAD (i.e. hypertension, diabetes, hyperlipidaemia, smoking habit, familial history, obesity), as well as determinants of tHcy levels. The population was subdivided into those having, or not, a substantial burden of traditional risk factors (i.e. < 4 and > or = 4, respectively).
There was a significant trend towards a reduced number of subjects within the group with > or = 4 risk factors across increasing tHcy levels (51.7%, 37.8%, 26%, for normal, moderate, intermediate tHcy, respectively, chi2 for linear-trend = 0.006). Folate and vitamin B12 concentrations, estimated glomerular filtration rate (GFR), MTHFR 677C > T polymorphism were the major determinants of tHcy in this population.
In patients with the same degree of CAD, those with hyperhomocysteinaemia had a reduced burden of traditional risk factors as compared with those with normal tHcy levels. Hyperhomocysteinaemia was significantly associated with an emerging non-traditional risk factor such as lower GFR.
为确定血浆总同型半胱氨酸(tHcy)中度至中度升高的常见情况是否会导致冠状动脉疾病(CAD),作者评估了患有相同程度CAD但tHcy水平不同的患者中并存的主要传统危险因素以及主要的tHcy决定因素。
作者研究了180例CAD患者,根据tHcy水平将其分为三组:60例tHcy正常的患者,60例中度(15 - 30 μmol/L)的患者和60例中度高同型半胱氨酸血症(30 - 100 μmol/L)的患者。患者组在性别、年龄和受累冠状动脉血管数量方面进行了匹配。所有患者均接受了CAD传统危险因素(即高血压、糖尿病、高脂血症、吸烟习惯、家族史、肥胖)以及tHcy水平决定因素的检查。该人群被细分为具有或不具有大量传统危险因素的人群(分别为<4个和≥4个)。
在具有≥4个危险因素的组中,随着tHcy水平升高,受试者数量有显著减少的趋势(正常、中度、中度tHcy组分别为51.7%、37.8%、26%,线性趋势χ² = 0.006)。叶酸和维生素B12浓度、估计肾小球滤过率(GFR)、MTHFR 677C>T多态性是该人群中tHcy的主要决定因素。
在患有相同程度CAD的患者中,与tHcy水平正常的患者相比,高同型半胱氨酸血症患者的传统危险因素负担较轻。高同型半胱氨酸血症与一种新出现的非传统危险因素如较低的GFR显著相关。